Background and aims Piecemeal endoscopic mucosal resection (EMR) is the standard
treatment of nodular Barrett's esophagus dysplasia and T1a cancer. Piecemeal resection …

Background Barrett's esophagus–related high-grade dysplasia or mucosal cancer can be
treated by endoscopic mucosal resection (EMR), but the adjacent metaplastic epithelium …

Objectives Endoscopic submucosal dissection (ESD) is carving out an increasing role in the
treatment of Barrett's associated neoplasia. ESD provides the advantage of en‐bloc …

Background The difference in clinical outcomes after endoscopic submucosal dissection
(ESD) and endoscopic mucosal resection (EMR) for early Barrett's esophagus (BE) …

Background and Aims Endoscopic submucosal dissection (ESD) is carving out an
increasing role in the treatment of esophageal neoplasia in the Western world. Contrary to …

Abstract Purpose of Review We aim to examine evidence on endoscopic submucosal
dissection (ESD) for managing Barrett's esophagus related neoplasia by a narrative review …

Background and study aims: The role of endoscopic submucosal dissection (ESD) in
Barrett's neoplasia is ill-defined, although it might provide a higher curative resection rate …

Background The use of endoscopic submucosal dissection (ESD) is gradually expanding for
treatment of neoplasia in Barrett's esophagus (BE). We aimed to report outcomes of all ESDs …

Introduction The possible benefit of endoscopic submucosal dissection (ESD) for early
neoplasia arising in Barrett's esophagus remains controversial. We aimed to assess the …

Barrett's esophagus (BE) is characterized by a change in the lining of the esophagus from
stratified squamous epithelium to a metaplastic columnar epithelium (IM) that has a low, but …